Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes

被引:26
|
作者
Ninomiya, Hiroyo [1 ]
Katakami, Naoto [1 ,2 ]
Sato, Ihoko [1 ]
Osawa, Saeko [1 ]
Yamamoto, Yuichi [1 ]
Takahara, Mitsuyoshi [1 ,3 ]
Kawamori, Dan [1 ]
Matsuoka, Taka-aki [1 ]
Shimomura, Iichiro [1 ]
机构
[1] Osaka Univ, Dept Metab Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Metab & Atherosclerosis, Grad Sch Med, Osaka, Japan
[3] Osaka Univ, Dept Diabet Care Med, Grad Sch Med, Osaka, Japan
关键词
Skin autofluorescence; Advanced glycation end products; Endothelial dysfunction; Atherosclerosis; Diabetes; INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; CORONARY-ARTERY-DISEASE; BRACHIAL-ARTERY; ENDOTHELIAL FUNCTION; SURROGATE MARKER; AUTOFLUORESCENCE; RISK; COMPLICATIONS; GUIDELINES;
D O I
10.5551/jat.44859
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: The level of accumulated advanced glycation end-products (AGEs) in the skin has been shown to predict the risk of complications in patients with diabetes mellitus (DM). Recently, the level of accumulated fluorescent AGEs in the skin has become measurable as skin autofluorescence (skin AF) using a non-invasive apparatus, autofluorescence reader. The purpose of this study was to evaluate the association between skin AF and the subclinical atherosclerosis markers, especially endothelial dysfunction, in patients with DM. Methods: We enrolled 140 Japanese subjects with DM who attended Osaka University Hospital, and measured the skin level of AGEs by skin AF and three subclinical atherosclerosis markers: endothelial function by flowmediated vasodilation, FMD; carotid intima-media thickness, IMT; and brachial-ankle pulse wave velocity, baPWV. Results: FMD was significantly associated with skin AF (r =-0.259, p= 0.002). Furthermore, a stepwise multivariate regression analysis revealed that skin AF was an independent determinant of FMD (beta=-0.180, p= 0.038). Although there were significant associations between skin AF and maximum carotid intima-media thickness (max-IMT)(r = 0.298, p< 0.001) as well as baPWV (r = 0.284, p= 0.001) in univariate analysis, skin AF was not an independent determinant of either carotid max-IMT or baPWV after adjustment for conventional cardiovascular risk factors. Receiver-operating characteristic curve analysis revealed that skin AF can identify the subjects whose FMD, max-IMT, and baPWV were completely within the normal range (C-statistics, 0.73; 95% confidence interval, 0.61-0.84; p< 0.001). Conclusions: Skin AF was independently associated with FMD as an indicator of endothelial dysfunction, and can be utilized as a screening marker of atherosclerosis in Japanese patients with DM.
引用
收藏
页码:1274 / 1284
页数:11
相关论文
共 50 条
  • [31] Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
    Jinluan Chen
    Banafsheh Arshi
    Komal Waqas
    Tianqi Lu
    Daniel Bos
    M. Arfan Ikram
    André G. Uitterlinden
    Maryam Kavousi
    M. Carola Zillikens
    Cardiovascular Diabetology, 22
  • [32] Advanced glycation end-products and cathepsin cysteine protease in type 2 diabetic patients
    Grzebyk, Ewa
    Knapik-Kordecka, Maria
    Piwowar, Agnieszka
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2013, 123 (7-8): : 364 - 370
  • [33] Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue
    Yue, X.
    Hu, H.
    Koetsier, M.
    Graaff, R.
    Han, C.
    DIABETIC MEDICINE, 2011, 28 (07) : 818 - 823
  • [34] The Association between the Level of Advanced Glycation End Products and Objective Skin Quality Parameters
    Martinovic, Dinko
    Tokic, Daria
    Usljebrka, Mislav
    Lupi-Ferandin, Slaven
    Cigic, Livia
    Vanjaka Rogosic, Lucija
    Ercegovic, Sasa
    Kontic, Mirko
    Kumric, Marko
    Rusic, Doris
    Vilovic, Marino
    Leskur, Mateo
    Bozic, Josko
    LIFE-BASEL, 2023, 13 (02):
  • [35] Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes
    Rigalleau, V.
    Cougnard-Gregoire, A.
    Nov, S.
    Gonzalez, C.
    Maury, E.
    Lorrain, S.
    Gin, H.
    Barberger-Gateau, P.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (02) : 270 - 274
  • [36] Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP
    Kyung, Sun Young
    Byun, Kyung Hee
    Yoon, Jin Young
    Kim, Yu Jin
    Lee, Sang Pyo
    Park, Jeong-Woong
    Lee, Bong Hee
    Park, Jong Sook
    Jang, An Soo
    Park, Choon Sik
    Jeong, Sung Hwan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 221 - 228
  • [37] Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkers
    Christidis, Grigorios
    Kueppers, Frederic
    Karatayli, Senem Ceren
    Karatayli, Ersin
    Weber, Susanne N.
    Lammert, Frank
    Krawczyk, Marcin
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [38] Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study
    Diallo, Alpha M.
    Jaisson, Stephane
    Barriquand, Romain
    Lukas, Celine
    Barraud, Sara
    Decoudier, Benedicte
    Francois, Maud
    Ly, Sang
    Mahmoudi, Rachid
    Arndt, Carl
    Nazeyrollas, Pierre
    Gillery, Philippe
    Delemer, Brigitte
    DIABETES THERAPY, 2022, 13 (08) : 1531 - 1546
  • [39] Advanced glycation end-products: new markers of renal dysfunction in patients with chronic heart failure
    Raposeiras-Roubin, Sergio
    Rodino-Janeiro, Bruno K.
    Grigorian-Shamagian, Lilian
    Moure-Gonzalez, Maria
    Seoane-Blanco, Ana
    Varela-Roman, Alfonso
    Alvarez, Ezequiel
    Gonzalez-Juanatey, Jose R.
    MEDICINA CLINICA, 2011, 136 (12): : 513 - 521
  • [40] Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
    Basta, G
    Schmidt, AM
    De Caterina, R
    CARDIOVASCULAR RESEARCH, 2004, 63 (04) : 582 - 592